• 1. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Organonitrogen compounds
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds

Dimethylsulfamyl Fluoride (CAS No. 354-44-9): A Comprehensive Overview

DIMETHYLSULFAMYL FLUORIDE, also known by its CAS registry number CAS NO. 354-44-9, is a fluorinated organic compound that has garnered significant attention in the field of biomedicine and pharmaceutical research. This compound belongs to the class of sulfonamides and is characterized by its unique chemical structure, which makes it a valuable tool in various scientific applications.

The structure of dimethylsulfamyl fluoride comprises a sulfonyl group flanked by two methyl substituents and a fluorine atom. This specific arrangement imparts the compound with distinct chemical properties, including reactivity towards nucleophilic substitution and potential for bioavailability in biological systems. These attributes have positioned it as an important intermediate in drug discovery and development processes.

Recent studies have highlighted the role of dimethylsulfamyl fluoride in the synthesis of biologically active molecules. For instance, researchers have explored its utility in the creation of fluorinated sulfonamides, which are known for their inhibitory effects on various enzyme pathways. This has led to its application in the development of anticancer, anti-inflammatory, and bacteriostatic agents.

In the realm of oncology, dimethylsulfamyl fluoride has been investigated as a precursor for fluorinated drugs that target specific cancer pathways. Its ability to facilitate site-specific fluorination in drug molecules has made it an indispensable reagent in the synthesis of cancer therapeutic agents. Furthermore, its role in enhancing the pharmacokinetic properties of drugs by introducing fluorine atoms has been extensively studied.

Beyond oncology, dimethylsulfamyl fluoride has also found applications in the development of antimicrobial agents. The introduction of fluorine into sulfonamide structures has been shown to enhance their efficacy against bacterial infections. This has led to its use in creating novel compounds that exhibit potent bactericidal activity, making them promising candidates for future antimicrobial therapies.

Recent advancements in chemical synthesis have further enhanced the utility of dimethylsulfamyl fluoride. Researchers have developed innovative methods to incorporate this compound into complex drug molecules, enabling the creation of highly selective and potent pharmaceutical agents. These methods include Suzuki-Miyaura coupling, Stille coupling, and other palladium-catalyzed reactions that leverage the unique reactivity of fluorinated sulfonamides.

The study of dimethylsulfamyl fluoride has also extended to its potential as a diagnostic agent. Its ability to facilitate the introduction of fluorine atoms into biomolecules has been explored in the context of imaging technologies, such as positron emission tomography (PET). This application holds promise for improving the accuracy of disease diagnosis and monitoring.

Despite its immense potential, the use of dimethylsulfamyl fluoride is not without challenges. The compound's reactivity must be carefully controlled to avoid unintended side reactions during drug synthesis. Additionally, the optimization of its pharmacokinetic properties remains an area of active research to ensure its safe and effective use in therapeutic applications.

Looking ahead, the continued exploration of dimethylsulfamyl fluoride's properties is expected to yield further breakthroughs in the field of biomedicine. Its role as a versatile reagent in drug discovery will likely expand, contributing to the development of next-generation therapies for a wide range of diseases.

• 32361-47-0(N-methylsulfamoyl fluoride)
• 34876-27-2(Amidosulfurous fluoride, dimethyl-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)